Wapnick Pamela bought MGX
April 1, 2026 · Form 4 insider transaction
Wapnick Pamela bought 24,000 shares of Metagenomi Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
24,000
Price
$0.00
Total value
N/A
InsiderWapnick Pamela
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateApril 1, 2026
Filing dateApril 3, 2026
Shares owned after211,375
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares represent restricted stock units ("RSUs"). 25% of the RSUs shall vest on June 5, 2027, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.